Conde, Arlyn D.
HRN: 07-09-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2023
CEFUROXIME 1.5GM (VIAL)
01/18/2023
01/25/2023
IV
1.5gm
Q8
T/C Sepsis, S/p NSVD-NID
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes